Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Toltrazuril
Bayer plc
QP51AJ01
Toltrazuril
Oral suspension
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Pigs, Sheep
Antiprotozoal anticoccidial
Authorized
2016-10-06
Revised: October 2020 AN: 00937/2020 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Baycox Multi 50 mg/ml oral suspension for Cattle, Pigs and Sheep For FI, DK, IS, SE: Baycoxine vet 50 mg/ml oral suspension for Cattle, Pigs and Sheep For NO: Baycoxine vet. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Toltrazuril 50 mg EXCIPIENTS: Sodium benzoate (E211) 2.1 mg Sodium propionate (E281) 2.1 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension White or yellowish suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves: dairy calves, beef suckler, bull beef), Pigs (Piglets, 3-5 days old), Sheep (lambs). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: For the prevention of clinical signs of coccidiosis and reduction of coccidia shedding in calves on farms with a confirmed history of coccidiosis caused by _Eimeria bovis_ or _Eimeria zuernii_. Pigs: For the prevention of clinical signs of coccidiosis in neonatal piglets (3-5 days old) on farms with a confirmed history of coccidiosis caused by _Cystoisospora suis_. Page 1 of 7 Revised: October 2020 AN: 00937/2020 Sheep: For the prevention of clinical signs of coccidiosis and reduction of coccidia shedding in lambs on farms with a confirmed history of coccidiosis caused by _Eimeria_ _crandallis_ and _Eimeria ovinoidalis_. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance or any of the excipients. 4.4 SPECIAL WARNINGS It is recommended to treat all animals in a pen. Hygienic measures may reduce the risk of coccidiosis. It is therefore, recommended to improve concomitantly the hygienic conditions in the concerned facility, particularly dryness and cleanliness. To obtain maximum benefit, animals should be treated before the expected onset of clinical signs, i.e. in the prepatent period. To alter the course of an established clinical coccidial infection, in individual animals already showing signs of diarrh Read the complete document